Patrick Donnelly
Stock Analyst at Citigroup
(3.68)
# 837
Out of 4,761 analysts
312
Total ratings
51.76%
Success rate
6.26%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Maintains: Buy | $23 → $20 | $10.90 | +83.49% | 11 | Feb 13, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Neutral | $600 → $650 | $532.55 | +22.05% | 18 | Jan 31, 2025 | |
| DHR Danaher | Maintains: Buy | $285 → $265 | $210.23 | +26.05% | 12 | Jan 30, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $300 → $290 | $201.39 | +44.00% | 8 | Jan 6, 2025 | |
| FTRE Fortrea Holdings | Downgrades: Neutral | $30 → $23 | $14.88 | +54.57% | 4 | Dec 11, 2024 | |
| ILMN Illumina | Downgrades: Neutral | $190 → $165 | $94.20 | +75.16% | 14 | Dec 11, 2024 | |
| MTD Mettler-Toledo International | Upgrades: Neutral | $1,200 → $1,300 | $1,286.54 | +1.05% | 11 | Dec 11, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 → $50 | $40.46 | +23.58% | 4 | Dec 11, 2024 | |
| SHC Sotera Health Company | Maintains: Buy | $18 → $20 | $13.52 | +47.93% | 3 | Nov 6, 2024 | |
| BRKR Bruker | Maintains: Buy | $80 → $75 | $50.82 | +47.58% | 14 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $49.26 | +52.25% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $450 | $312.05 | +44.21% | 14 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $450 | $280.08 | +60.67% | 14 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $185 | $172.24 | +7.41% | 10 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $95 → $85 | $64.49 | +31.80% | 13 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $215 → $175 | $163.02 | +7.35% | 19 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $135.37 | +21.89% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $42.87 | +4.97% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $20.90 | +33.97% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $113.84 | +27.37% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $17.30 | +32.95% | 7 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $85 | $64.92 | +30.93% | 10 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $39.57 | +56.18% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $374.82 | -19.96% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.80 | +136.84% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $225 | $191.04 | +17.78% | 9 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $4.12 | -33.25% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $249.85 | +4.06% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $4.72 | +27.25% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $14.18 | +125.67% | 2 | Nov 30, 2018 |
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $23 → $20
Current: $10.90
Upside: +83.49%
Thermo Fisher Scientific
Jan 31, 2025
Maintains: Neutral
Price Target: $600 → $650
Current: $532.55
Upside: +22.05%
Danaher
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $210.23
Upside: +26.05%
ICON Public Limited Company
Jan 6, 2025
Maintains: Buy
Price Target: $300 → $290
Current: $201.39
Upside: +44.00%
Fortrea Holdings
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $14.88
Upside: +54.57%
Illumina
Dec 11, 2024
Downgrades: Neutral
Price Target: $190 → $165
Current: $94.20
Upside: +75.16%
Mettler-Toledo International
Dec 11, 2024
Upgrades: Neutral
Price Target: $1,200 → $1,300
Current: $1,286.54
Upside: +1.05%
QuidelOrtho
Dec 11, 2024
Upgrades: Buy
Price Target: $44 → $50
Current: $40.46
Upside: +23.58%
Sotera Health Company
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $13.52
Upside: +47.93%
Bruker
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $50.82
Upside: +47.58%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $49.26
Upside: +52.25%
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $450
Current: $312.05
Upside: +44.21%
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $450
Current: $280.08
Upside: +60.67%
Oct 23, 2024
Maintains: Buy
Price Target: $165 → $185
Current: $172.24
Upside: +7.41%
Oct 1, 2024
Downgrades: Neutral
Price Target: $95 → $85
Current: $64.49
Upside: +31.80%
Oct 1, 2024
Downgrades: Sell
Price Target: $215 → $175
Current: $163.02
Upside: +7.35%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $135.37
Upside: +21.89%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $42.87
Upside: +4.97%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $20.90
Upside: +33.97%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $113.84
Upside: +27.37%
Jul 10, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $17.30
Upside: +32.95%
May 22, 2024
Downgrades: Neutral
Price Target: $85
Current: $64.92
Upside: +30.93%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $39.57
Upside: +56.18%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $374.82
Upside: -19.96%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.80
Upside: +136.84%
Dec 11, 2023
Maintains: Neutral
Price Target: $190 → $225
Current: $191.04
Upside: +17.78%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $4.12
Upside: -33.25%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $249.85
Upside: +4.06%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $4.72
Upside: +27.25%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $14.18
Upside: +125.67%